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Nutrition in the critically ill patient !
Jane Gervasio !
Critical illness presents with the classic response to stress, including hypermetabolism and 
increased catabolism, resulting in a negative energy and nitrogen balance. These harmful events 
initiate the immunological response, starting with the systemic inflammatory response syndrome, 
which, if not resolved, may lead to multiple organ dysfunction syndrome (MODS). Furthermore, 
patients who do not develop early MODS manifest a compensation anti-inflammatory response 
syndrome, which suppresses immunity and predisposes the patient to sepsis, thereby increasing 
the risk of late MODS and ultimately death. The use of specialized nutrition support, including 
enteral nutrition (EN) and parenteral nutrition (PN), has been initiated in an attempt to preserve 
muscle wasting and decrease catabolic response. Other implementations, including hypocaloric 
feeding and immune-enhancing agents, have also been investigated for their help in improving 
outcomes in the critically ill patient. !
Energy expenditure 
 
Alteration in energy expenditure is well established in the critically ill patient. Substantial 
increases in resting energy expenditure during critical illness, especially trauma, thermal injury 
and sepsis, have been reported. The use of predictive formulations (ie, the Harris-Benedict 
equation) plus additional factors to account for severity of injury and activity to determine 
energy expenditure in the critically ill patient are fraught with errors, leading to overfeeding of 
the patient. Recommendations from published studies and guidelines, including the American 
College of Chest Physicians (ACCP) and the American Society for Parenteral and Enteral 
Nutrition Clinical Guidelines Task Force, suggest initially providing 25–30kcal/kg/day and 1–
1.5g protein/kg/day to critically ill patients.1,2 
  
Research investigating decreasing caloric delivery (approximately 33–65% of ACCP 
recommendations) during the acute phase of illness or injury have reported less days of 
ventilation, fewer infections and decreased intensive care and hospital length of stay.3-5 
McCowen et al performed a prospective, randomized trial in 40 patients, comparing PN delivery 
of 25kcal/kg/day and 1.5g of protein/kg/day to hypocaloric PN delivery of a total of 1,000kcal 
and 70g of protein per day. Decreased rates of infections (29% vs 54%, p=0.11) and mortality 
(9% vs 16%) were reported in the group receiving hypocaloric nutrition.4 While more 
prospective, randomized trials are necessary, the early results from these studies are intriguing. !
Delivery of specialized nutrition support 
 
The use of EN is the preferred method of nutrient delivery if the small intestine is functional and 
capable of absorption. EN over PN has been shown to decrease infections, particularly 
pneumonia, line infections and, in the trauma patient, abdominal abscesses. And while 
differences in mortality have not been shown between EN and PN, studies have reported reduced 
!1
MODS and decreases in length of intensive care and hospital stay, leading to decreased hospital 
costs.2,6,7 !
No clear evidence has been established to answer the question why the use of EN appears 
beneficial versus PN, but theories have been postulated. A long-held theory, "bacterial 
translocation", is that atrophy of the gastrointestinal (GI) tract resulting from disuse contributes 
to facilitating or permitting the translocation of enteric bacteria or their metabolic products into 
the circulation. Circulating bacteria may predispose the patient to infections and sepsis.8 !
A second theory has been postulated, proposing immunological communication between the GI 
tract and mucosal surfaces throughout the body via a common mucosal immunity. Failure to feed 
the GI tract results in alterations in the gut-associated lymphoid tissue which, in turn, lead to 
changes in GI vascularity and decreased production of IgA. Ultimately, these changes result in an 
increase in the inflammatory response to secondary insults in the lungs, liver and GI tract.9,10 
  
Concerning the use of PN, a number of studies and recommended guidelines support only using 
PN in the malnourished critically ill patient in whom EN is not possible.2,11 In those patients for 
whom there is no evidence of protein-calorie malnutrition, the use of PN should be reserved and 
initiated only after the first 7–10 days.2 !
Early EN is also considered advantageous in the critical ill patient. Patients resuscitated and 
haemodynamically stable should have EN initiated within 24–48 hours.11,12 A meta-analysis by 
Marik and Zaloga reviewed 15 prospective randomized clinical trials of early versus delayed EN 
in critically ill patients and found that early enteral feeding was associated with decreased 
infections (relative risk reduction 0.45; 95% CI 0.30–0.66; p=0.00006) and reduced length of 
stay (relative risk reduction 2.2 days; 95% CI 0.81–3.63 days; p=0.004).13,14 
  
Gastric or postpyloric routes of delivery may be used for EN. In a systematic review of 
prospective, randomized clinical trials, the incidence of pneumonia, intensive care unit (ICU) 
length of stay and mortality were similar between both gastric and postpyloric routes of feeding. 
Gastric feeding was initiated significantly sooner due to the delay in achieving postpyloric 
intubations.15 Small bowel feedings should be considered in the critically ill patient at risk for 
regurgitation and aspiration and in those patients at high risk for intolerance to EN.11 !
Tools to help decrease the critically ill patients risk for regurgitation and aspiration include -
raising the head of the bed to 45˚ when possible. A significant reduction in clinically suspected -
nosocomial pneumonia was reported by Drakulovic and colleagues when patients were placed in 
a semirecumbent position compared with patients in the supine position (8% vs 34%; 95% CI for 
difference 10.0–42.0, p=0.003). Furthermore, the highest frequency of nosocomial pneumonia 
was observed in patients receiving EN in the supine position.16 !!!
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Immune-enhancing agents 
 
Immune-enhancing diets (IED) are the combination of some or all of the nutrients, including 
glutamine, arginine, omega-3 fatty acids and nucleotides to nutritionally complete enteral 
formulas. A number of studies investigating the use of immune-enhancing EN in the critically ill 
patients (ie, trauma, thermally-injured and surgery) have reported fewer infections and decreased 
ventilatory days, as well as decreased ICU and hospital length of stay.11,17,18 The United States 
Summit on Immune-Enhancing Enteral Therapy recommended that patients who should receive 
early enteral IED include moderately to severely malnourished patients undergoing upper GI 
tract surgery or severely malnourished patients undergoing lower GI surgery, and trauma patients 
with an injury severity score ≥18 or an Abdominal Trauma Index ≥20. The consensus panel 
believed other populations, including head injury (Glasgow Coma Scale <8), thermal injury 
(≥30%; third degree), ventilator-dependent (nonseptic medical and surgical patients) and 
selective elective surgery patients may benefit from an IED.(17) A follow-up article reviewing 
IED studies in the critically ill patient, published after the Summit further substantiated the 
original recommendations.18 !
However, controversy does exist regarding the use of IED. The Canadian Guidelines 
recommended that diets supplemented with arginine not be used for critically ill patients.11 
Additionally, others have stated that it is "inappropriate to recommend glutamine for therapeutic 
use in any condition" due to limited available data.19 Unarguably, while many smaller studies are 
available, large, prospective randomized trials with IED would be helpful. !
Conclusion 
 
Delivery of specialized nutrition support in the critically ill patient helps decrease nitrogen 
expenditure. Early initiation of EN significantly improves outcome in the critically ill patient. PN 
should be reserved for those patients considered protein-malnourished and unable to tolerate EN. 
IED may be considered but the patient's clinical condition must first be assessed. !
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